14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
Google cut costs by rescinding offers to more than 2,000 contract workers due to the strains of the ...
Read More >
Strengthening Buy American statutes have been a rare area of bipartisan agreement in the current fra...
Read More >
Sharp, attentive, long-time followers of this update expressed dismay last year when I declared the ...
Read More >
On August 6, 2019, New Jersey enacted its Wage Theft Law, transforming the state’s wage and hour la...
Read More >
The Federal Antimonopoly Service strengthens enforcement of foreign investments legislation - Esta...
Read More >
The Empire State Development Corporation (“ESDC”) issued guidance over the weekend clarifying the ...
Read More >